Society for Translational Oncology navigateright Episode
Clonal hematopoiesis of indeterminate potential (CHIP) is a common, age-associated condition in individuals who do not have a hematologic malignancy or altered blood counts. Consistent with the concept that CHIP is a pre-malignant state, CHIP is associated with a striking increased risk of hematologic malignancy. In addition, individuals with CHIP have increased overall mortality and an increased risk of cardiovascular disease.
Benjamin Ebert, MD, PhD
Dana-Farber Cancer Institute
STO gratefully acknowledges educational grants in partial support of this activity from:
Novartis Pharmaceuticals Corp.